← Back to patent-cliff list
Bisoprolol Patches(Toa Eiyo)
Tier C — Watch / tradeBisoprolol Patches(Toa Eiyo)
Toa Eiyo Ltd
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ADRB1
Brand：Bisono
Indications (approved)：Tachycardia, Atrial fibrillation, Essential hypertension
Regional status
US
-
EU
-
China
Filed / under review
2026-06-18
Japan
Approved
2013-06-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bisoprolol Patches(Toa Eiyo)?
Approved indications include: Tachycardia, Atrial fibrillation, Essential hypertension.
When does the Bisoprolol Patches(Toa Eiyo) patent expire?
No public expiry year is available for Bisoprolol Patches(Toa Eiyo) yet; this page updates once verified.
How do I get a quote for Bisoprolol Patches(Toa Eiyo) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29